The study enrolled more than 2,900 patients who had a history of a major atherosclerotic cardiovascular disease event (ASCVD) or who were at an increased risk for such an episode." Merck's PCSK9 pill holds 'significant advantage' with injectable-like cholesterol reductions: analysts fiercebiotech.com To view or add a comment, sign in Breaking from #AHA25 The phase 3 CORALreef HeFH trial brings a major step forward: the first oral PCSK9 inhibitor, enlicitide, cuts LDL-C by 60% vs placebo in adults with heterozygous familial hypercholesterolemia already on maximally tolerated statins
Severe B12 deficiency is widely reported and leads to pernicious anemia since your body needs B12 to make red blood cells, and a deficiency limits its capabilities to build them
HbA1c provides an indication of average blood glucose concentrations over the preceding 2 to 3 months
doi: 10.1016/j.cell.2016.04.009 8 LewerenzJHewettSJHuangYLambrosMGoutPWKalivasPWet al
This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews